about
Multi-Country analysis of palm oil consumption and cardiovascular disease mortality for countries at different stages of economic development: 1980-1997The costs of reducing loss to follow-up in South African cervical cancer screening.Economic evaluation research in the context of Child Welfare policy: a structured literature review and recommendationsCost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysisCost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United StatesDisease control implications of India's changing multi-drug resistant tuberculosis epidemicPalm oil taxes and cardiovascular disease mortality in India: economic-epidemiologic modelProgram spending to increase adherence: South African cervical cancer screeningCost-effectiveness of treatment of diabetic macular edema.Tuberculosis treatment discontinuation and symptom persistence: an observational study of Bihar, India's public care system covering >100,000,000 inhabitantsEstimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.Quantifying child mortality reductions related to measles vaccination.Modeling and calibration for exposure to time-varying, modifiable risk factors: the example of smoking behavior in India.Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients.Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.Screening with OGTT alone or in combination with the Indian diabetes risk score or genotyping of TCF7L2 to detect undiagnosed type 2 diabetes in Asian IndiansSofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in U.S. incarcerated populations: a cost-effectiveness analysisEstimating the cost of cervical cancer screening in five developing countriesEvaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters.Diabetes, its treatment, and catastrophic medical spending in 35 developing countries.Quantifying demographic and socioeconomic transitions for computational epidemiology: an open-source modeling approach applied to India.Research aimed at improving both mood and weight (RAINBOW) in primary care: A type 1 hybrid design randomized controlled trial.An Efficient, Noniterative Method of Identifying the Cost-Effectiveness FrontierMental health services use by children investigated by child welfare agenciesRisk stratification in compartmental epidemic models: Where to draw the line?Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination.Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling.New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysisEvaluating child welfare policies with decision-analytic simulation models.Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants.Cost-Effectiveness of Implantable Pulmonary Artery Pressure Monitoring in Chronic Heart FailureCost-effectiveness of statins for primary cardiovascular prevention in chronic kidney diseaseAnalyzing Screening Policies for Childhood Obesity.Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression MetamodelingTrade-offs in cervical cancer prevention: balancing benefits and risks.Exploration and Adoption of Evidence-based Practice by US Child Welfare Agencies.Explaining variations in state foster care maintenance rates and the implications for implementing new evidence-based programs.Providers' knowledge of diagnosis and treatment of tuberculosis using vignettes: evidence from rural Bihar, India.The business case for quality improvement: oral anticoagulation for atrial fibrillation.
P50
Q21203901-fa5a5938-44ef-9ad6-1ff7-edc390abe1b8Q24815385-ce3dc506-47e4-2707-05c0-1ad3a170abdaQ26824669-663e8919-4613-e5ed-70cb-1fe50135fd8fQ28267134-8fe953b9-43f4-4b62-8a22-2691bb130b99Q28485350-c96a87b8-45be-e052-8472-6276d963882aQ28488762-d0f2193b-42f1-d4c4-42fb-cb102ecb5cd8Q28540633-05d4bbd7-4d1f-de43-1015-795fe13c562bQ28603638-de340b09-44c2-e0f8-027f-056e89aa218cQ33459276-919bb263-45ef-2e48-14f5-51e27f3e20b9Q33606611-fff7a7e4-4c5a-2e7b-fcc7-ee9ca3bfdbb3Q33696669-473de681-488f-e8f0-c2fe-80e8886bd0cfQ33724701-453ffa07-4ca6-fd20-651f-80ecf43b0d50Q33747882-78f68baf-42fc-cfa2-6b4f-d186fe807b9aQ33969384-7dae1279-455d-28ab-5da0-a3d69b3f916aQ34098870-a21d2db7-4836-85d5-6357-56ab8bca5efaQ34997604-a6180f4d-4fb7-6323-1976-a0999b3e52afQ35010449-110f3f4d-405e-707a-1d84-89c462adebbaQ35037688-2403ac2a-4e54-5df7-9b28-59bccf75d62fQ35039416-462a112c-448a-b88f-4d88-8f31b2183f16Q35564876-b338575e-40f2-e568-4f57-ff571eda0107Q35688372-5ab84ff5-4993-4a6d-3152-9ddf24386f83Q35906207-0b92578b-495e-2f0b-9a2e-8b5998c7e44dQ35957450-cc08ef06-4415-acf8-dd08-5a00a56532f6Q36225897-2df4b91b-4e13-6433-32c4-b6f3b5ec036dQ36355980-009be4d7-42b9-8abb-6bb1-6addb8f6019aQ36399819-3e49f5f2-42bf-9dc5-f45f-a68a7edb4e6aQ36404994-4b77736a-40fd-4097-c3f6-15f140cfd1daQ36584372-baafb4e7-4c51-c55b-88f3-4617c2fb9251Q36652084-270dc46a-4875-3e0f-de94-4806abf9b28aQ36660220-7c3d7df6-4f65-bad5-1ef9-dc8e57e33071Q36752754-bfeb9bb3-429b-3493-3565-06fa175a033dQ36853325-68c04272-4540-c4e7-390d-9a96dc929168Q36943996-a79f24df-47f6-eca7-8dfb-cea24f1675abQ37097475-7fe296db-49cf-910b-2619-aaf7295b0ae7Q37163118-9585c840-422a-1e6b-d347-d11cbcb5f4e7Q37352821-a11b3083-4ee7-c9ed-6948-890bd00bc23aQ37649560-9200965e-453d-a1e8-a69b-1ddc36705e9cQ37649567-e847bbf8-4daa-8809-7930-6c8fe8b7881bQ37659994-fd5a2982-43e9-c036-6b78-46d44e8af6cbQ37666333-1db34c99-459d-6332-c64e-044899e0db05
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Jeremy Goldhaber-Fiebert
@ast
Jeremy Goldhaber-Fiebert
@en
Jeremy Goldhaber-Fiebert
@es
Jeremy Goldhaber-Fiebert
@nl
type
label
Jeremy Goldhaber-Fiebert
@ast
Jeremy Goldhaber-Fiebert
@en
Jeremy Goldhaber-Fiebert
@es
Jeremy Goldhaber-Fiebert
@nl
altLabel
J D Goldhaber-Fiebert
@en
J. D. Goldhaber-Fiebert
@en
Jeremy D Goldhaber-Fiebert
@en
Jeremy D. Goldhaber-Fiebert
@en
prefLabel
Jeremy Goldhaber-Fiebert
@ast
Jeremy Goldhaber-Fiebert
@en
Jeremy Goldhaber-Fiebert
@es
Jeremy Goldhaber-Fiebert
@nl
P1006
P214
P244
P1006
P1960
_pYGFUwAAAAJ
P21
P213
0000 0001 1536 7348
P214
P244
n2011180357
P2456
P31
P496
0000-0002-4007-5192
P7859
lccn-n2011180357